China Nuokang Q2 net revenue falls
The company has posted a net income of RMB14.14m for the second quarter of 2011, compared to RMB19.39m for the same period in 2010. China Nuokang has generated
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.